Skip to main navigation

Skip to Content

Kinnate Investor Navigation

Overview
News & Events
- Press Releases
- Events & Presentations
Financial Information
- SEC Filings
- Annual Reports
Corporate Governance
Stock Information
Investor Resources

Price
Change

stock chart

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Tools

Press Releases

Year

Kinnate Biopharma Inc. Appoints Neha Krishnamohan as CFO and Executive Vice President, Corporate Development and Expands its Leadership Team with Key New Hires

Jun 07, 2021

Read More

Kinnate Biopharma Inc. Presents Preclinical Data From its Lead RAF Inhibitor Candidate KIN-2787 at ASCO 2021

Jun 04, 2021

Read More

Kinnate Biopharma Inc. to Participate at the Goldman Sachs 42nd Annual Global Healthcare Conference

May 25, 2021

Read More

Kinnate Biopharma Inc. Reports First Quarter 2021 Financial Results and Announces FDA Clearance of Investigational New Drug Application for KIN-2787

May 17, 2021

Read More

Kinnate Biopharma Inc. Closes $35 Million Series A Financing to Establish a Chinese Joint Venture

May 13, 2021

Read More

Kinnate Biopharma Inc. to Present Pre-Clinical Data from its RAF Kinase Inhibitor Program at Annual ASCO Meeting

May 10, 2021

Read More

Kinnate Biopharma Inc. Announces the Departure of Dr. Stephen Kaldor from its Board of Directors

Apr 30, 2021

Read More

Kinnate Biopharma Inc. Reports Full Year 2020 Financial Results

Mar 29, 2021

Read More

Kinnate Biopharma Inc. Announces Its Addition to the Russell 2000® Index

Mar 19, 2021

Read More

Kinnate Biopharma Inc. to Participate in Upcoming Investor Conferences

Feb 11, 2021

Read More

© 2021 Kinnate Biopharma

Kinnate Footer Legal

Terms of Use
Privacy